Clinical Trials

34 enrolled

Hematologic Neoplasms

NCT06184321 2025-12-26

Alteplase Through an Indwelling Pleural Catheter for the Management of Symptomatic Septated Malignant Pleural Effusion

30 enrolled

Hematologic Neoplasms

NCT04744116 2025-11-10

Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease

24 enrolled

Hematologic Neoplasms

NCT06398457 2025-09-26

Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

8 enrolled

Anemia, Aplastic, Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

NCT07117175 2025-08-12

A Clinical Study to Evaluate the Safety and Efficacy of Anti-human CD 7 CAR-NK Cell Injection in Subjects With Relapsed and Refractory CD7-positive Hematological Malignancy

18 enrolled

Phase EARLY_PHASE1 Terminated

Hematologic Neoplasms

NCT03579446 2025-08-03

Levorphanol as a Second Line Opioid in Reducing Pain in Patients With Cancer

43 enrolled

Neoplasm Metastasis, Hematologic Neoplasms

NCT06837389 2025-02-20

Early Clinical Study of JY306 Universal NK Cell Injection in the Treatment of Adult Relapsed or Refractory CD70+ Malignant Hematologic Tumors

18 enrolled

Recurrence, Hematologic Neoplasms

NCT05923541 2024-11-22

RD13-02 for Patients With r/r CD7+ T Cell Hematologic Malignancies

6 enrolled

Hematologic Neoplasms

NCT05716113 2024-11-21

CD7 CAR-T for Patients With r/r CD7+ T-ALL/T-LBL

Hematologic Diseases, Neoplasms, Neoplasms by Site, Hematologic Neoplasms

NCT05902845 2024-11-21

RD13-02 CAR-T Cell Injection for Patients With r/r CD7+ T-ALL/T-LBL

4 enrolled

Hematologic Diseases, Neoplasms, Hematologic Neoplasms

NCT05907603 2024-11-21

Research Development（RD）13-02 Chimeric Antigen Receptor(CAR) -T Cell Injection for Patients With r/r Cluster Of Differentiation 7（CD7）+ T-Acute Lymphoblastic Leukemia(ALL)/T-Lymphoblastic Lymphoma(LBL) /Acute Myelogenous Leukemia(AML)

8 enrolled

Hematologic Diseases, Neoplasms, Hematologic Neoplasms

NCT04742595 2024-10-29

Viral Specific T Cell Therapy for COVID-19 Related Pneumonia

32 enrolled

Hematologic Neoplasms

NCT03537482 2024-08-19

APG-2575 Study of Safety, Tolerability ,PK/PD in Patients With Hematologic Malignancies

90 enrolled

Phase EARLY_PHASE1 Terminated

Hematologic Neoplasms

NCT05284032 2024-07-31

A Pilot Trial Using Isatuximab to Overcome Platelet Transfusion Refractoriness in Human Leukocyte Antigen Allo-Immunized Patients (SuppCare 001)

3 enrolled

Hematologic Neoplasms

NCT05707325 2024-07-24

Reboot-101

30 enrolled

Phase EARLY_PHASE1 Terminated

Neoplasms, Hematologic Neoplasms

NCT03272633 2023-06-26

Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies

2 enrolled 6 charts

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Chromosome 17 deletion, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Neoplasm, Residual, Hematologic Neoplasms, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04803630 2022-05-12

Thermal Therapy for the Treatment of Depression in Cancer Survivors, the S-WARM Study

Phase EARLY_PHASE1 Withdrawn

Hematologic Neoplasms

NCT03795779 2021-05-19

CLL1-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic Malignancies

MyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT04700319 2021-03-08

CAR-T CD19/CD20 for Patients With Advanced CD19/CD20+ B Cell Line Recurrent or Refractory Hematological Malignancies

30 enrolled

Hematologic Neoplasms

NCT04767308 2021-02-23

Safety and Efficacy of CT125A Cells for Treatment of Relapsed/Refractory CD5+ Hematopoietic Malignancies

LymphoidOther hematologic neoplasm

18 enrolled

Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral, Hematologic Neoplasms, Lymphoma, Mantle-Cell

NCT04662788 2020-12-10

Clinical Study on the Safety and Effectiveness of NK Cells/Combined Monoclonal Antibodies in the Treatment of Hematological Malignancies

36 enrolled

Hematologic Neoplasms

NCT04657965 2020-12-08

LMP1 CAR-T for Patients With LMP1 Positive Infectious Diseases and Hematological Malignancies

144 enrolled

Communicable Diseases, Hematologic Neoplasms

NCT04156256 2019-11-12

CD123-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic Malignancies

MyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT04011293 2019-07-08

A Clinical Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Injection (CNCT19) in the Treatment of Cluster of Differentiation 19 (CD19) Positive Relapsed or Refractory B Cell Malignancies

Neoplasms, Recurrence, Hematologic Neoplasms

NCT00896792 2018-10-09

Nurse Practitioner Hospice Program for Patients With Terminal Metastatic Cancer and Their Families or Caregivers

26 enrolled